Tolerx
American biotech company focused on immune tolerance therapies.
Last updated August 25, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Tolerx is an American biotech company focused on developing immune tolerance therapies for autoimmune and inflammatory diseases. Its pipeline includes otelixizumab for type 1 diabetes.
Products and positioning
Cite this profile: Cite the canonical profile. /brand-wiki/tolerx · Editorial policy · How profiles are compiled